To assess the antiarrhythmic effect of L-carnitine, propafenone and mexiletine, we tested the drugs in 50 patients with effort angina and ventricular ectopic beats (VEB). The patients were randomized in 5 groups: Group A: was treated with oral L-carnitine at the dose of 2 g x 3 for two weeks. Group B: oral propafenone at the dose of 300 mg x 3 for two weeks. Group C: as group B + L-carnitine + g x 3 at the second weeks. Group D: oral mexiletine at the dose of 200 mg x 3 for two weeks. Group E: as group D + L-carnitine 2 gr x 3 at the second week. After 7 and 14 days of treatment, in all patients an Holter examination was performed. Our results show that L-carnitine exerts a significant reduction of the VEB and its administration potentiates the antiarrhythmic effect of propafenone and mexiletine.
|Translated title of the contribution||Arrhythmias and myocardial ischemia: Effect of L-carnitine in association with propafenone or mexiletine|
|Number of pages||6|
|Publication status||Published - 1995|
ASJC Scopus subject areas